Table 1.

The clinical symptoms of myasthenia gravis patients before and after treatment.

Variables	Case group	Treatment group	p value
Gender (Female)	15 (50%)	15 (50%)	NA
Age-years	59.47 ± 13.33	59.47 ± 13.33	NA
ASMG	13.56 ± 9.36	3.52 ± 3.06	0.001
RSMG (Total efficiency)	NA	93.86 ± 5.62	NA
MGFA	9.56 ± 4.23	2.36 ± 1.56	0.025
ADLMG	6.52 ± 3.17	1.65 ± 1.03	0.032

Note: ASMG, Absolute score of myasthenia gravis; RSMG, Relative score of myasthenia gravis; MGFA, Myasthenia gravis foundation of America; ADLMG, Activities of daily living of myasthenia gravis.